hotspot -WSS

hotspot

author：fashion 2025-10-01 17:20:41 - browse：4

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： WuXi Biologics execs register to lobby as Congress comes for the company

hotspot

WSS

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Boston hospital trains restaurant workers on naloxone for overdoses

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Galapagos to make CAR

STAT series 'Denied by AI' wins major journalism prizes

Wikipedia

hotspot

focus

Peter Hotez and the public health issue of online harassment

UnitedHealth argues against case alleging wrongful AI care denials

Walensky prepares to leave CDC — and Congress — behind

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Dobbs anniversary: the lost opportunity of abortion as health care

Ripples from Flovent's discontinuation is killing children with asthma

State Dept. review finds Biden bears some blame for Afghanistan failures

H5N1 bird flu outbreak: Second human case reported, in Michigan

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Hottest summer in 2,000 years puts focus on extreme heat, health

entertainment

Cherokee Nation medical school graduates its first class

Obesity drug from Roche shows promise in early study

UnitedHealth argues against case alleging wrongful AI care denials

Supreme Court to hear if Covid misinformation is protected speech

Investigation reveals sickle cell patients pressured into sterilizations

Listen: More tumult at BIO & coercive care for sickle cell patients

focus

hotspot

hotspot

entertainment